Vimarsana
Biggest News Aggregation in the World

Page 7 - Launch Dynamix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Launch Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Launch Dynamix Today - Breaking & Trending Today

AbbVie's Rinvoq Already Flexing Its Promotional and Efficacy Muscles to Impact the Ulcerative Colitis Market, According to Spherix Global Insights - Vimarsana News

AbbVie's Rinvoq Already Flexing Its Promotional and Efficacy Muscles to Impact the Ulcerative Colitis Market, According to Spherix Global Insights

/PRNewswire/ -- According to the latest deep dive report published as part of Spherix's Launch Dynamix™: Rinvoq in Ulcerative Colitis (US) service, AbbVie's...

Spherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan - Vimarsana News

Spherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan

/PRNewswire/ -- Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Berger's...

Spherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan - Vimarsana News

Spherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan

/PRNewswire/ -- Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Berger's...

Ophthalmologists Welcome Genentech's Vabysmo, Though Overthrowing Regeneron's Eylea Will Be No Small Feat, Spherix Reports - Vimarsana News

Ophthalmologists Welcome Genentech's Vabysmo, Though Overthrowing Regeneron's Eylea Will Be No Small Feat, Spherix Reports

/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...

Ophthalmologists Welcome Genentech's Vabysmo, Though Overthrowing Regeneron's Eylea Will Be No Small Feat, Spherix Reports - Vimarsana News

Ophthalmologists Welcome Genentech's Vabysmo, Though Overthrowing Regeneron's Eylea Will Be No Small Feat, Spherix Reports

/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...